Western Europe

The $250m sought for Vertex Growth III would make it at least 40% smaller than its predecessor.

UK pension schemes’ shift towards private markets is supported by policy, regulation and infrastructure, but the pace will depend on fee mechanics and closing the growth capital gap, according to senior execs at Schroders.

Inflows during the period were disproportionately buoyed by the $49bn raised for MGX Fund I in June.

The power of the global M&A market increasingly hinges on the presence of mega-deals.

In this podcast, Amadeus Capital Partners' chief executive, who is known as the Godmother of European venture capital, speaks with PEI's Adam Le about what the AI boom means for investors and more.

In today's edition, GPs eyeing retail capital are having to tread a delicate tightrope; A European GP defies headwinds to surpass its initial hard-cap; Temasek-linked Azalea joins the evergreen fray.

The manager of Novo Nordisk Foundation’s $36bn of investments is expanding its planetary health portfolio and mulling carving out an allocation for private equity GPs to run, according to partner Aleks Engel.

The private equity model isn’t broken, but the illusion of uniform success is, writes Scott Hart, partner and chief executive at StepStone Group.

A $67bn pension is hunting for software bargains; CVC nearly doubles its mid-market target; How much transparency is too much transparency?

Private capital should not be viewed as a replacement for government funding, but rather as a catalyst that brings commercial discipline and scale, according to the director general of the Royal United Services Institute speaking at a UK Private Capital event.